Targeting Mitochondria to Control Ageing and Senescence

Data de publicació

2023-02-09T04:16:35Z

2023-02-09T04:16:35Z

2023-01-30

2023-02-08T08:30:18Z

Resum

Ageing is accompanied by a progressive impairment of cellular function and a systemic deterioration of tissues and organs, resulting in increased vulnerability to multiple diseases. Here, we review the interplay between two hallmarks of ageing, namely, mitochondrial dysfunction and cellular senescence. The targeting of specific mitochondrial features in senescent cells has the potential of delaying or even reverting the ageing process. A deeper and more comprehensive understanding of mitochondrial biology in senescent cells is necessary to effectively face this challenge. Here, we discuss the main alterations in mitochondrial functions and structure in both ageing and cellular senescence, highlighting the differences and similarities between the two processes. Moreover, we describe the treatments available to target these pathways and speculate on possible future directions of anti-ageing and anti-senescence therapies targeting mitochondria.

Tipus de document

Article


Versió publicada

Llengua

Anglès

Publicat per

MDPI

Documents relacionats

Reproducció del document publicat a: https://doi.org/10.3390/pharmaceutics15020352

Pharmaceutics, 2023, vol. 15, num. 2, p. 352

https://doi.org/10.3390/pharmaceutics15020352

Citació recomanada

Aquesta citació s'ha generat automàticament.

Drets

cc by (c) Protasoni, Margherita et al., 2023

http://creativecommons.org/licenses/by/3.0/es/

Aquest element apareix en la col·lecció o col·leccions següent(s)